Skip to content

Treatment of scalp ringworm in unani system of medication.

Clinical study on the Efficacy of Sharbate Unnab with Tila Kibreet Kundur and Ushaq versus Clotrimazole 1 percent Lotion in Tinea Capitis A Randomized Single Blind Controlled Clinical Trial. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099528
Enrollment
32
Registered
2025-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Sharbate Unnab orally and Tila kibreet kundur ushaq topically: Oral administration of Sharbate Unnab will Be given as follow 5ml for less than and equal to 5years old or 10ml to 6 to 1

Sponsors

National Institute of Unani Medicine Kottigepalya magadi main road bengaluru India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Clinically diagnosed and Mycologically confirmed cases of tinea capitis. 2.Aged between 4 to 60yrs. 3.Subjects with 3 Patterns of tinea capitis inclunding grey patch black dots and kerion. 4.All gender

Exclusion criteria

Exclusion criteria: 1.Subjects with history of systemic treatment for 4 week and topical treatment taken 2week before enrollment. 2.Known cases of severe tinea capitis means Favus 3.known cases of diabetes mellitus 4.Subjects with history of seborrheic dermatitis scalp psoriasis or other scalp conditions.

Design outcomes

Primary

MeasureTime frame
1.Decrease in 5D Itch Scale 2.Negative KoH Mounting. Timepoint: 1.Baseline 7th 14th and 21st day 2.Baseline and 21st day

Secondary

MeasureTime frame
1.Change in photography of lesions. 2.Trichoscopy changes. Timepoint: Baseline 7th 14th and 21st day

Countries

India

Contacts

Public ContactProff Mohd Aleemuddin Quamri

National Institute of Unani Medicine

drmaquamri@gmail.com9341072974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026